Highlights Nanotechnology-based systems are proposed for targeted co-delivery of analgesic and anticancer agents in cervical cancer. Transdermal and intravaginal nanocarrier platforms offer localized, sustained, and low-toxicity pain management. Comprehensive overview of organic, inorganic, and hybrid nanocarriers for cervical cancer therapy. Surface-functionalized nanocarriers enable active and passive targeting for improved therapeutic precision.
Odei-Mensah et al. (Fri,) studied this question.